Sangamo Therapeutics, Inc.
NASDAQ:SGMO
Overview | Financials
Company Name | Sangamo Therapeutics, Inc. |
Symbol | SGMO |
Currency | USD |
Price | 2.87 |
Market Cap | 597,594,270 |
Dividend Yield | 0% |
52-week-range | 0.29 - 3.175 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
Website | https://www.sangamo.com |
An error occurred while fetching data.
About Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD